Zydus Lifesciences has informed that it enclosed a copy of press release dated December 2, 2022 titled ‘Zydus receives final approval from the USFDA for Estradiol Transdermal System which will be manufactured at the Moraiya plant'.
The above information is a part of company’s filings submitted to BSE.